Real World Neuroscience Leverage Cyrebro Neurosignals' platform, which analyzes EEG and behavioral data in real-life contexts to quantify how products affect users' brains. Target opportunities where UX and product testing decisions can be accelerated, such as consumer electronics, automotive, healthcare devices, gaming, and advertising research. Propose pilot engagements with product teams to demonstrate measurable brain-activity insights that inform design choices and marketing claims.

AI Driven Dashboards Offer a scalable analytics solution built around automated dashboards and strategic AI models that translate complex neural data into actionable business metrics. Emphasize integration readiness with common data ecosystems to fit into client tech stacks and reduce time-to-value. Position as a differentiator for product validation, user experience optimization, and evidence-based ROI.

Investor Backing Recent funding momentum from Koch Disruptive Technologies and Elaia indicates strong capital support and credibility. Use the investor network to facilitate introductions to enterprise clients and potential co-development partners across technology and healthcare verticals. Highlight the company's scalability trajectory to reassure large customers about long-term support.

Hardware Partnerships The EEG-centric platform aligns with hardware providers and device manufacturers. Pursue co-development, data interoperability, and bundled solutions with EEG hardware vendors, VR/AR platforms, and digital-health device makers. These partnerships can expand reach, shorten sales cycles, and create integrated offerings for real-world brain analytics.

European Growth Based in Paris with a Europe-focused footprint, Cyrebro Neurosignals can capitalize on EU digital health and neuroscience innovation ecosystems. Target EU-based enterprises, research institutions, and biotechs seeking real-world brain data insights, while aligning with EU data privacy and regulatory requirements to facilitate adoption and expansion.